Lemmens, Stéphanie M. P. http://orcid.org/0000-0002-0312-897X
Lopes van Balen, Veronica A.
Röselaers, Yvonne C. M.
Scheepers, Hubertina C. J.
Spaanderman, Marc E. A.
Funding for this research was provided by:
ZonMw (209010006)
Article History
Received: 13 April 2020
Accepted: 11 January 2022
First Online: 17 February 2022
Declarations
:
: The Expect-II trial (reference number 17-N-60, Zuyderland Medical Center, Heerlen, The Netherlands) consisted of the development and validation of prediction models on adverse pregnancy outcomes and the development of care pathways for defined high risk pregnancies. Pregnant women gave written informed consent to participate. The involved healthcare professionals gave verbal consent to participate during a meeting at the start of the project. The current project included a process analysis, of which the questions were not clear upfront. Therefore, no detailed consent from an ethical board was obtained for this specific part. At this point, we cannot change this unfortunately.
: Not applicable.
: There are no financial, personal or other influences for any author that may affect the objectivity of this manuscript.